Publications by authors named "Andrew Duncombe"

Claim this Profile
S
Simple hyperinflammation scores predict mortality in hospitalized patients with COVID-19 and offer a personalized medicine approach to dexamethasone intervention.
Alexandra E Oppong, Leda Coelewij, Matthew Hutchinson, Ben Carpenter, George A Robinson, Andrew S Duncombe

Int J Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The commercial elephant in the room.
Andrew Duncombe

Future Healthc J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathways to myeloproliferative neoplasm presentation and time to diagnosis: results from a cross-sectional study.
Emma-Louise Tarburn, Lisa Iversen, Charlotte Robertson, Charlene McShane, Andrew Duncombe

BJGP Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare on a burning planet.
Andrew Duncombe

Future Healthc J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new prescription.
Andrew Duncombe

Future Healthc J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence: friend or foe?
Andrew Duncombe

Future Healthc J· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The origin of the .
Andrew Duncombe

Future Healthc J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How do we improve the resilience of our healthcare systems and staff ?
Andrew Duncombe

Future Healthc J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and investigation of suspected haemophagocytic lymphohistiocytosis in adults: 2023 Hyperinflammation and HLH Across Speciality Collaboration (HiHASC) consensus guideline.
Miriam F Cox, Strachan Mackenzie, Ryan Low, Michael Brown, Emilie Sanchez, Andrew Duncombe

Lancet Rheumatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The aetiology and burden of myeloproliferative neoplasms in the United Kingdom: the MyelOproliferative neoplasmS: an In-depth case-control (MOSAICC) study protocol.
Nouf Abutheraa, Emma-Louise Tarburn, Charlene M McShane, Andrew Duncombe, Mary Frances McMullin

BMC Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden.
Lai Yee Orbell, Nouf Abutheraa, Andrew S Duncombe, Mary Frances McMullin, Ruben Mesa

EJHaem· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A hyperinflammation clinical risk tool, HI5-NEWS2, stratifies hospitalised COVID-19 patients to associate risk of death and effect of early dexamethasone in an observational cohort.
Michael R Ardern-Jones, Hang T T Phan, Florina Borca, Matt Stammers, James Batchelor, Andrew S Duncombe

PLoS One· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioblastoma, IDH-wildtype: A New Association with IgM Paraproteinaemic Neuropathy?
Dana M Lewis, Nancy T H Colchester, David Allen, James A R Nicoll, Haider A Katifi, Andrew S Duncombe

Case Rep Neurol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary haemophagocytic lymphohistiocytosis in hospitalised COVID-19 patients as indicated by a modified HScore is infrequent and high scores do not associate with increased mortality.
Michael R Ardern-Jones, Matt Stammers, Hang Tt Phan, Florina Borca, Anastasia Koutalopoulou, Andrew S Duncombe

Clin Med (Lond)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm.
Richard A Salisbury, Natalia Curto-Garcia, Jennifer O'Sullivan, Frederick Chen, Paolo Polzella, Andrew Duncombe

Leukemia· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating promastocytes and atypical mast cells in systemic mastocytosis associated with acute myelogenous leukaemia transformation.
Mohammed O A Altohami, Dana Lewis, Andrew S Duncombe

EJHaem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoimmunotherapy with rituximab, cyclophosphamide and prednisolone in IgM paraproteinaemic neuropathy: evidence of sustained improvement in electrophysiological, serological and functional outcomes.
Nancy T H Colchester, David Allen, Haider A Katifi, Tracy Burt, Robert N Lown, Andrew S Duncombe

Haematologica· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial.
Andrew R Pettitt, Richard Jackson, Silvia Cicconi, Fotis Polydoros, Christina Yap, Andrew Duncombe

Haematologica· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refractory CIDP with chronic lymphocytic leukaemia responding to chemoimmunotherapy.
Dana Lewis, Chinar Osman, David Allen, Ashwin Arnold Pinto, Andrew Duncombe

Pract Neurol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modifiable Lifestyle and Medical Risk Factors Associated With Myeloproliferative Neoplasms.
Andrew S Duncombe, Lesley A Anderson, Glen James, Frank de Vocht, Lin Fritschi

Hemasphere· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia.
Nicholas C P Cross, Yvette Hoade, William J Tapper, Gonzalo Carreno-Tarragona, Tiziana Fanelli, Andrew S Duncombe

Leukemia· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic variants.
Hemanth Tummala, Arran D Dokal, Amanda Walne, Alicia Ellison, Shirleny Cardoso, Andrew S Duncombe

Proc Natl Acad Sci U S A· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MOSAICC study: Assessing feasibility for biological sample collection in epidemiology studies and comparison of DNA yields from saliva and whole blood samples.
Glen James, Mary Frances McMullin, Andrew S Duncombe, Mike Clarke, Lesley A Anderson

Ann Hum Genet· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guideline for the investigation and management of eosinophilia.
Nauman M Butt, Jonathan Lambert, Sahra Ali, Philip A Beer, Nicholas C P Cross, Andrew Duncombe

Br J Haematol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controls.
Lesley A Anderson, Glen James, Andrew S Duncombe, Ruben Mesa, Robyn Scherber

Am J Hematol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis